The relentless pursuit of novel therapeutics hinges on the availability of precise and high-quality chemical building blocks. Among these, heterocyclic compounds play a particularly vital role, and the quinazoline scaffold is a prominent example. This article delves into the specific significance of 7-Benzyloxy-4-chloro-6-methoxyquinazoline (CAS: 162364-72-9) within the landscape of drug discovery and pharmaceutical development. For R&D scientists and formulators, understanding its chemical attributes and application potential is crucial for advancing innovative treatments.

7-Benzyloxy-4-chloro-6-methoxyquinazoline is more than just a chemical compound; it's a strategic component in the synthesis of complex pharmaceutical agents. Its quinazoline core, embellished with a benzyloxy group, a chloro atom, and a methoxy substituent, grants it a unique reactivity profile. The chloro group, in particular, serves as an excellent leaving group, facilitating nucleophilic substitution reactions, which are fundamental in building diverse molecular libraries. This makes it an attractive starting material for chemists aiming to create a wide array of drug candidates. Researchers often seek out such intermediates to buy when initiating new synthetic pathways.

The primary application domain for this compound lies in the synthesis of targeted therapies, especially for diseases like cancer and inflammatory conditions. Many kinase inhibitors, a crucial class of anti-cancer drugs, are based on the quinazoline structure. By strategically modifying the substituents on the quinazoline ring, scientists can develop molecules with high specificity and efficacy, minimizing off-target effects. The benzyloxy group can enhance lipophilicity, potentially improving cell membrane permeability and oral bioavailability – key considerations in drug formulation. This makes the compound a valuable asset for any pharmaceutical company looking to expand its pipeline of innovative drugs. If you are considering sourcing this intermediate, look for terms like 'pharmaceutical intermediate manufacturer' or 'high purity chemical supplier' when performing your search.

Beyond its direct role in API synthesis, 7-Benzyloxy-4-chloro-6-methoxyquinazoline is also instrumental in medicinal chemistry research. It acts as a scaffold for generating libraries of compounds for high-throughput screening (HTS). By systematically varying the functional groups attached to this core structure, researchers can rapidly identify lead compounds with promising biological activity. The availability of this intermediate from reliable manufacturers, often at competitive pricing, allows research institutions and biotech firms to accelerate their discovery programs. Companies looking for such compounds can search for '7-benzyloxy-4-chloro-6-methoxyquinazoline CAS 162364-72-9' to pinpoint available sources.

In summary, 7-Benzyloxy-4-chloro-6-methoxyquinazoline is an indispensable tool in modern drug discovery. Its versatile chemical structure and reactivity make it a cornerstone for synthesizing a new generation of pharmaceuticals. As a key intermediate, its availability from reputable suppliers in China, offering high purity and consistent quality, is critical for advancing healthcare solutions. Researchers and procurement specialists are encouraged to explore partnerships with dedicated chemical providers to ensure a steady supply of this essential compound.